Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF)
USD 1.27
(0.0%)
USD 1.27
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 7.66 Billion CNY | -14.95% |
| 2022 | 9.01 Billion CNY | 9.86% |
| 2021 | 8.2 Billion CNY | 14.21% |
| 2020 | 7.18 Billion CNY | 15.62% |
| 2019 | 6.21 Billion CNY | 19.31% |
| 2018 | 5.2 Billion CNY | -0.38% |
| 2017 | 5.22 Billion CNY | 24.27% |
| 2016 | 4.2 Billion CNY | 14.12% |
| 2015 | 3.68 Billion CNY | 12.76% |
| 2014 | 3.26 Billion CNY | 6.35% |
| 2013 | 3.07 Billion CNY | 9.96% |
| 2012 | 2.79 Billion CNY | -2.71% |
| 2011 | 2.87 Billion CNY | 38.39% |
| 2010 | 2.07 Billion CNY | 460.1% |
| 2009 | 370.74 Million CNY | 126.57% |
| 2008 | 163.63 Million CNY | 33.47% |
| 2007 | 122.6 Million CNY | 44.96% |
| 2006 | 84.57 Million CNY | 38.16% |
| 2005 | 61.21 Million CNY | -59.22% |
| 2004 | 150.11 Million CNY | -31.62% |
| 2003 | 219.51 Million CNY | 14.56% |
| 2002 | 191.61 Million CNY | -5.77% |
| 2001 | 203.34 Million CNY | -6.91% |
| 2000 | 218.44 Million CNY | 58.86% |
| 1999 | 137.5 Million CNY | 52.88% |
| 1998 | 89.94 Million CNY | 193.55% |
| 1997 | 30.64 Million CNY | 69.23% |
| 1996 | 18.1 Million CNY | -15.24% |
| 1995 | 21.36 Million CNY | -7.2% |
| 1994 | 23.01 Million CNY | -2.72% |
| 1993 | 23.66 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 2.5 Billion CNY | 4.68% |
| 2024 Q3 | 1.83 Billion CNY | -26.65% |
| 2024 Q1 | 2.39 Billion CNY | 115.39% |
| 2023 FY | 7.66 Billion CNY | -14.95% |
| 2023 Q1 | 2.49 Billion CNY | 78.75% |
| 2023 Q3 | 1.99 Billion CNY | -3.37% |
| 2023 Q2 | 2.06 Billion CNY | -16.99% |
| 2023 Q4 | 1.11 Billion CNY | -44.38% |
| 2022 FY | 9.01 Billion CNY | 9.86% |
| 2022 Q4 | 1.39 Billion CNY | -23.53% |
| 2022 Q3 | 1.82 Billion CNY | -52.1% |
| 2022 Q2 | 3.8 Billion CNY | 90.67% |
| 2022 Q1 | 1.99 Billion CNY | 42.08% |
| 2021 Q4 | 1.4 Billion CNY | -10.63% |
| 2021 Q3 | 1.57 Billion CNY | -29.8% |
| 2021 FY | 8.2 Billion CNY | 14.21% |
| 2021 Q1 | 2.99 Billion CNY | 75.29% |
| 2021 Q2 | 2.23 Billion CNY | -25.19% |
| 2020 Q3 | 1.84 Billion CNY | -9.63% |
| 2020 FY | 7.18 Billion CNY | 15.62% |
| 2020 Q1 | 1.59 Billion CNY | 24.53% |
| 2020 Q2 | 2.04 Billion CNY | 28.1% |
| 2020 Q4 | 1.7 Billion CNY | -7.45% |
| 2019 Q2 | 1.84 Billion CNY | 10.91% |
| 2019 FY | 6.21 Billion CNY | 19.31% |
| 2019 Q1 | 1.66 Billion CNY | 264.55% |
| 2019 Q3 | 1.43 Billion CNY | -22.22% |
| 2019 Q4 | 1.27 Billion CNY | -10.71% |
| 2018 FY | 5.2 Billion CNY | -0.38% |
| 2018 Q2 | 1.55 Billion CNY | 1.76% |
| 2018 Q3 | 1.66 Billion CNY | 7.1% |
| 2018 Q1 | 1.52 Billion CNY | 3.83% |
| 2018 Q4 | 455.51 Million CNY | -72.67% |
| 2017 Q4 | 1.47 Billion CNY | 31.2% |
| 2017 Q3 | 1.12 Billion CNY | -10.66% |
| 2017 FY | 5.22 Billion CNY | 24.27% |
| 2017 Q1 | 1.37 Billion CNY | 53.63% |
| 2017 Q2 | 1.25 Billion CNY | -8.64% |
| 2016 Q4 | 895.38 Million CNY | -10.83% |
| 2016 FY | 4.2 Billion CNY | 14.12% |
| 2016 Q1 | 1.12 Billion CNY | 44.85% |
| 2016 Q2 | 1.18 Billion CNY | 5.17% |
| 2016 Q3 | 1 Billion CNY | -15.12% |
| 2015 Q4 | 776.49 Million CNY | -13.16% |
| 2015 FY | 3.68 Billion CNY | 12.76% |
| 2015 Q3 | 894.2 Million CNY | -12.2% |
| 2015 Q1 | 997.49 Million CNY | 50.31% |
| 2015 Q2 | 1.01 Billion CNY | 2.1% |
| 2014 Q1 | 850.93 Million CNY | 20.0% |
| 2014 FY | 3.26 Billion CNY | 6.35% |
| 2014 Q4 | 663.63 Million CNY | -11.46% |
| 2014 Q3 | 749.57 Million CNY | -25.44% |
| 2014 Q2 | 1 Billion CNY | 18.15% |
| 2013 FY | 3.07 Billion CNY | 9.96% |
| 2013 Q1 | 885.91 Million CNY | 49.75% |
| 2013 Q2 | 764.16 Million CNY | -13.74% |
| 2013 Q4 | 709.11 Million CNY | -0.84% |
| 2013 Q3 | 715.11 Million CNY | -6.42% |
| 2012 FY | 2.79 Billion CNY | -2.71% |
| 2012 Q4 | 591.59 Million CNY | 2.93% |
| 2012 Q2 | 818.38 Million CNY | 0.9% |
| 2012 Q1 | 811.12 Million CNY | 71.82% |
| 2012 Q3 | 574.77 Million CNY | -29.77% |
| 2011 Q1 | 1.21 Billion CNY | 176.69% |
| 2011 Q2 | 577.28 Million CNY | -52.65% |
| 2011 Q3 | 537.51 Million CNY | -6.89% |
| 2011 Q4 | 472.06 Million CNY | -12.18% |
| 2011 FY | 2.87 Billion CNY | 38.39% |
| 2010 Q1 | 578.98 Million CNY | 449.51% |
| 2010 FY | 2.07 Billion CNY | 460.1% |
| 2010 Q2 | 548.58 Million CNY | -5.25% |
| 2010 Q3 | 508.36 Million CNY | -7.33% |
| 2010 Q4 | 440.62 Million CNY | -13.32% |
| 2009 FY | 370.74 Million CNY | 126.57% |
| 2009 Q4 | 105.36 Million CNY | -7.68% |
| 2009 Q3 | 114.13 Million CNY | 77.51% |
| 2009 Q2 | 64.29 Million CNY | -26.06% |
| 2009 Q1 | 86.95 Million CNY | 2683.94% |
| 2008 Q3 | 56.73 Million CNY | -5.9% |
| 2008 Q1 | 49.98 Million CNY | 257.74% |
| 2008 FY | 163.63 Million CNY | 33.47% |
| 2008 Q2 | 60.28 Million CNY | 20.61% |
| 2008 Q4 | -3.36 Million CNY | -105.93% |
| 2007 Q4 | 13.97 Million CNY | -64.59% |
| 2007 Q3 | 39.45 Million CNY | 28.95% |
| 2007 Q2 | 30.59 Million CNY | -20.68% |
| 2007 FY | 122.6 Million CNY | 44.96% |
| 2007 Q1 | 38.57 Million CNY | 285.46% |
| 2006 Q4 | -20.79 Million CNY | -178.71% |
| 2006 FY | 84.57 Million CNY | 38.16% |
| 2006 Q1 | 37.23 Million CNY | 207.64% |
| 2006 Q2 | 41.71 Million CNY | 12.01% |
| 2006 Q3 | 26.42 Million CNY | -36.65% |
| 2005 Q4 | -34.59 Million CNY | -219.55% |
| 2005 FY | 61.21 Million CNY | -59.22% |
| 2005 Q1 | 49.2 Million CNY | 383.23% |
| 2005 Q3 | 28.94 Million CNY | 63.85% |
| 2005 Q2 | 17.66 Million CNY | -64.11% |
| 2004 FY | 150.11 Million CNY | -31.62% |
| 2004 Q4 | -17.37 Million CNY | -137.53% |
| 2004 Q1 | 62.89 Million CNY | -15.48% |
| 2004 Q2 | 58.29 Million CNY | -7.31% |
| 2004 Q3 | 46.29 Million CNY | -20.59% |
| 2003 Q3 | 34.54 Million CNY | -46.19% |
| 2003 FY | 219.51 Million CNY | 14.56% |
| 2003 Q4 | 74.4 Million CNY | 115.37% |
| 2003 Q2 | 64.21 Million CNY | 38.54% |
| 2003 Q1 | 46.34 Million CNY | -23.43% |
| 2002 Q3 | 33.94 Million CNY | -36.66% |
| 2002 FY | 191.61 Million CNY | -5.77% |
| 2002 Q1 | 43.53 Million CNY | 0.0% |
| 2002 Q4 | 60.53 Million CNY | 78.31% |
| 2002 Q2 | 53.59 Million CNY | 23.11% |
| 2001 FY | 203.34 Million CNY | -6.91% |
| 2000 FY | 218.44 Million CNY | 58.86% |
| 1999 FY | 137.5 Million CNY | 52.88% |
| 1998 FY | 89.94 Million CNY | 193.55% |
| 1997 FY | 30.64 Million CNY | 69.23% |
| 1996 FY | 18.1 Million CNY | -15.24% |
| 1995 FY | 21.36 Million CNY | -7.2% |
| 1994 FY | 23.01 Million CNY | -2.72% |
| 1993 FY | 23.66 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| China Medicine Corporation | 12.26 Million USD | -62406.545% |
| DH Enchantment Inc. | -145.23 Thousand USD | 5279146.746% |
| Exlites Holdings International, Inc. | -15.49 Thousand USD | 49498064.519% |
| Itonis, Inc. | -38.31 Thousand USD | 20013764.067% |
| One Step Vending Corp. | -27.79 Thousand USD | 27590005.376% |
| MediPal Holdings Corporation | 312.71 Million USD | -2351.821% |
| PD-Rx Pharmaceuticals, Inc. | -190.47 Thousand USD | 4025381.112% |
| Pharmagen, Inc. | -2159.03 USD | 355124146.632% |
| Suzuken Co., Ltd. | 230.42 Million USD | -3227.421% |